AIM: To investigate biogenesis and intracellular localizations of clusterin to elucidate the potential molecular mechanisms implicated in tumorigenesis of esophageal mucosa. METHODS: Semi-quantitative RT-PCR for multi-region alteration analysis, Western blot for different transcriptional forms and immunohistochemical staining for intracellular localizations of clusterin were carried out in both tissues and cell lines of ESCC. RESULTS: The N-terminal deletions of the clusterin gene and the appearance of a 50-53 ku nuclear clusterin, an uncleaved, nonglycosylated, and disulfide-linked isoform, were the major alterations in cancer cells of esophagus. Naturally the 40 ku clusterin was located in the connective tissue of the lamina propria of epithelial mucosa and right under the basal membrane of epithelia, but it was disappeared in stromal mucosa of esophagus and the pre-matured clusterin was found positive in cancerous epithelia. CONCLUSION: The N-terminal deletion of clusterin may be essential for its alterations of biogenesis in ESCC.
AIM: To investigate biogenesis and intracellular localizations of clusterin to elucidate the potential molecular mechanisms implicated in tumorigenesis of esophageal mucosa. METHODS: Semi-quantitative RT-PCR for multi-region alteration analysis, Western blot for different transcriptional forms and immunohistochemical staining for intracellular localizations of clusterin were carried out in both tissues and cell lines of ESCC. RESULTS: The N-terminal deletions of the clusterin gene and the appearance of a 50-53 ku nuclear clusterin, an uncleaved, nonglycosylated, and disulfide-linked isoform, were the major alterations in cancer cells of esophagus. Naturally the 40 ku clusterin was located in the connective tissue of the lamina propria of epithelial mucosa and right under the basal membrane of epithelia, but it was disappeared in stromal mucosa of esophagus and the pre-matured clusterin was found positive in cancerous epithelia. CONCLUSION: The N-terminal deletion of clusterin may be essential for its alterations of biogenesis in ESCC.
Authors: Konstantin S Leskov; Dmitry Y Klokov; Jing Li; Timothy J Kinsella; David A Boothman Journal: J Biol Chem Date: 2003-01-24 Impact factor: 5.157
Authors: C R Yang; K Leskov; K Hosley-Eberlein; T Criswell; J J Pink; T J Kinsella; D A Boothman Journal: Proc Natl Acad Sci U S A Date: 2000-05-23 Impact factor: 11.205
Authors: I Viard; P Wehrli; L Jornot; R Bullani; J L Vechietti; J A Schifferli; J Tschopp; L E French Journal: J Invest Dermatol Date: 1999-03 Impact factor: 8.551
Authors: J Steinberg; R Oyasu; S Lang; S Sintich; A Rademaker; C Lee; J M Kozlowski; J A Sensibar Journal: Clin Cancer Res Date: 1997-10 Impact factor: 12.531
Authors: Konstantin S Leskov; Shinako Araki; John-Paul Lavik; Jose A Gomez; Vivian Gama; Efstathios S Gonos; Ioannis P Trougakos; Shigemi Matsuyama; David A Boothman Journal: J Biol Chem Date: 2011-09-27 Impact factor: 5.157
Authors: Ula V Jurkunas; Maya S Bitar; Ian Rawe; Deshea L Harris; Kathryn Colby; Nancy C Joyce Journal: Invest Ophthalmol Vis Sci Date: 2008-03-31 Impact factor: 4.799
Authors: Min Zhou; Defen Shen; James E Head; Emily Y Chew; Patricia Chévez-Barrios; W Richard Green; Chi-Chao Chan Journal: Mol Vis Date: 2007-11-15 Impact factor: 2.367
Authors: Olesya Chayka; Daisy Corvetta; Michael Dews; Alessandro E Caccamo; Izabela Piotrowska; Giorgia Santilli; Sian Gibson; Neil J Sebire; Nourredine Himoudi; Michael D Hogarty; John Anderson; Saverio Bettuzzi; Andrei Thomas-Tikhonenko; Arturo Sala Journal: J Natl Cancer Inst Date: 2009-04-28 Impact factor: 13.506
Authors: Lucinda Craggs; Julie Taylor; Janet Y Slade; Aiqing Chen; Christian Hagel; Gregor Kuhlenbaeumer; Anne Borjesson-Hanson; Matti Viitanen; Hannu Kalimo; Vincent Deramecourt; Arthur E Oakley; Raj N Kalaria Journal: Neuropathol Appl Neurobiol Date: 2015-06-17 Impact factor: 8.090